Healthcare Services Group, Inc.

For Q2 2026, revenue was $470.8 million, net income was $22.7 million, and diluted EPS was $0.32. Cash flow from operations was $21.9 million, or $27.9 million excluding the $6 million decrease in payroll accrual. Segment revenue was $213.2 million for Environmental Services at a 13.3% margin and $257.6 million for Dietary Services at a 7.5% margin. Cost of services was $396 million, or 84.1%, and SG&A was $52.6 million, or $45.7 million after adjusting for $6.9 million of deferred compensation. The effective tax rate was 26.8%, and management expects the 2026 tax rate to be approximately 25%. For Q3, revenue is expected in the $475 million-$485 million range, and management reaffirmed a 2026 mid-single-digit growth outlook.

Ted Wahl emphasized that demand for HCSG’s services remains strong and said the company has a robust pipeline of new business opportunities, with timing of management capacity and client start dates the key factor in converting that pipeline into revenue. He also highlighted a multi-decade demographic tailwind, stable industry occupancy and reimbursement, and the company’s ability to pass through unavoidable cost increases. His tone was confident and upbeat, especially about the second half of 2026 and the long-term opportunity set.

Vikas Singh focused on liquidity, margins, and capital allocation. He said cash and marketable securities were $200.9 million, the $300 million revolver was undrawn except for letters of credit, and the company repurchased $20.9 million of stock in Q2, bringing year-to-date buybacks to $44.9 million, with 8.3 million shares remaining under authorization. On margins, he pointed to lower bad debt expense, service execution, and a $1.3 million workers' comp/general liability benefit as drivers of the quarter, while noting that those insurance benefits are expected to trend toward zero over time and can be lumpy quarter to quarter.

Analysts focused on the implied second-half revenue ramp, cost trends, bad debt, insurance benefit volatility, Genesis bankruptcy exposure, and the M&A pipeline. Management said the back-half ramp is driven mainly by pipeline timing rather than a single segment, that bad debt was $4.3 million in Q2 and historically runs around 1%-1.5% of revenue, and that the insurance reserve benefit averaged about $3 million quarterly over the last few years but could range from about $1.5 million to $4.5 million. On Genesis, Ted Wahl said services continue without disruption and the sale is expected to close in late Q3 or early Q4; on M&A, Vikas Singh said the pipeline is more robust than 6-18 months ago and the company is selectively pursuing small deals.